MAMuhammad Asif

Muhammad Asif

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammad Asif has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic

    by Zeeshan Ahmad Bhutta, Ayesha Kanwal, Moazam Ali, Muhammad Fakhar-E-Alam Kulyar, Wangyuan Yao, Muhammad Shoaib, Ambreen Ashar, Ashar Mahfooz, Misbah Ijaz, Nabeel Ijaz, et al.

    The COVID-19 outbreak is creating severe impressions on all facets of the global community. Despite strong measures worldwide to try and re-achieve normalcy, the ability of SARS-CoV-2 to survive sturdy ecological settings may contribute to its rapid spread. Scientists from different aspects of life are working together to develop effective treatment strategies against SARS-CoV-2. Apart from using clinical devices for patient recovery, the key focus is on developing antiviral drugs and vaccines. Given the physical size of the SARS-CoV-2 pathogen and with the vaccine delivery platform currently undergoing clinical trials, the link between nanotechnology is clear, and previous antiviral research using nanomaterials confirms this link. Nanotechnology based products can effectively suppress various pathogens, including viruses, regardless of drug resistance, biological structure, or physiology. Thus, nanotechnology is opening up new dimensions for developing new strategies for diagnosing, preventing, treating COVID-19 and other viral ailments. This article describes the application of nanotechnology against the COVID-19 virus in terms of therapeutic purposes and vaccine development through the invention of nanomaterial based substances such as sanitizers (handwashing agents and surface disinfectants), masks and gowns, amongst other personal protective equipment, diagnostic tools, and nanocarrier systems, as well as the drawbacks and challenges of nanotechnology that need to be addressed.


  • Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO2NPs) and Their Jeopardy to Human Population

    by Samina Shabbir, Muhammad Fakhar-E-Alam Kulyar, Zeeshan Ahmad Bhutta, Prerona Boruah, Muhammad Asif

    Titanium dioxide nanoparticles (TiO2 NPs) are the most produced nanomaterial for food additives, pigments, photocatalysis, and personal care products. These nanomaterials are at the forefront of rapidly developing indispensable nanotechnology. In all these nanomaterials, titanium dioxide (TiO2) is the most common nanomaterial which is being synthesized for many years. These nanoparticles of TiO2 are widely used at the commercial level, especially in cosmetic industries. High usage in such a way has increased the toxicological consequences of the human population. Several studies have shown that TiO2 NPs accumulated after oral exposure or inhalation in the alimentary canal, lungs, heart, liver, spleen, cardiac muscle, and kidneys. Additionally, in mice and rats, they disturb glucose and lipid homeostasis. Moreover, TiO2 nanoparticles primarily cause adverse reactions by inducing oxidative stress that leads to cell damage, inflammation, genotoxicity, and adverse immune responses. The form and level of destruction are strongly based on the physical and chemical properties of TiO2 nanoparticles, which administer their reactivity and bioavailability. Studies give indications that TiO2 NPs cause both DNA strand breaks and chromosomal damages. The effects of genotoxicity do not depend only on particle surface changes, size, and exposure route, but also relies on the duration of exposure. Most of these effects may be because of a very high dose of TiO2 NPs. Despite increased production and use, epidemiological data for TiO2 NPs is still missing. This review discusses previous research regarding the impact of TiO2 NP toxicity on human health and highlights areas that require further understanding in concern of jeopardy to the human population. This review is important to point out areas where extensive research is needed; thus, their possible impact on individual health should be investigated in more details.


  • Open Access

    Conventional Medicine in the Treatment of Different Diseases as a Complementary and Alternative Medicine

    by Muhammad Fakhar-E-Alam Kulyar, Zeeshan Ahmad Bhutta, Moazam Ali, Shah Nawaz, Muhammad Asif

    Traditional medicine is still the only treatment in many rural areas especially the rural communities of east. Due to limited access to modern medicine, local people use medicinal plants to treat most diseases. Some herbs contain powerful contents and must be treated with the same precautionary care as in the case of drug, we do. In fact, a lot of drugs are basically based on artificial verities of natural composite in plants. For example, the heart drug Digitalis comes from a foxglove plant. Some drugs are single active substance derived from botanical sources. Herbalists believe that if the active ingredient is isolated from other parts of the plant, its action may be lost or its safety may be reduced. E.g, salicylic acid is present in a plant of meadowsweet which is used for aspirin production. Aspirin may cause bleeding in the gastric mucosa, but meadowsweet contains some other compounds naturally that interfere with the stimulation of salicylic acid. According to some practitioners, the effect of whole plant is greater than its parts individually. Critics believe that the nature of the herbs makes itself difficult to administer of such active ingredients. Herbs contain active ingredients, Mostly of them have unknown ingredients. As with other prescription drugs, herbs should always be prescribed by a qualified doctor.